Recent research has shed light on the potential of nicotinamide riboside (NR) as a promising supplement for the treatment of Parkinson's disease. For those facing this challenging condition, this new insight offers hope and a potential new path to improvement.
Safety and Tolerance of High-Dose NR
In a meticulous study involving 20 individuals with idiopathic Parkinson’s, conducted by leading neurologists, it was found that NR, even at high doses of 3000 mg per day, is safe and well-tolerated. Over a four-week period, participants were closely monitored, reporting no significant side effects. This is encouraging news for patients concerned about the potential risks of new supplements.
Impact on Clinical Symptoms
Even more remarkable is the finding that NR can significantly improve the clinical symptoms of Parkinson's. The study utilized the MDS-UPDRS scale, a recognized method used by doctors and researchers to assess the severity of Parkinson's symptoms. Results showed that patients taking NR experienced noticeable improvements in their daily functioning and overall quality of life.
Increased NAD+ Levels and Their Significance
One of the most crucial findings from the study is the significant increase in blood NAD+ levels among participants taking NR. NAD+ plays a vital role in cellular health and energy production, which is particularly relevant in neurodegenerative diseases like Parkinson’s, where cellular dysfunction is a central issue.
These research findings are promising and suggest that NR supplements could be a valuable addition to existing treatment strategies for Parkinson’s, with the potential to both improve the quality of life and slow the progression of symptoms. We remain committed to providing reliable and useful information about the benefits of our products for your health and well-being.
For more detailed information, you can view the study on this BioSpace article.
